Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
2019; Ferrata Storti Foundation; Volume: 105; Issue: 9 Linguagem: Inglês
10.3324/haematol.2019.236588
ISSN1592-8721
AutoresJill Corre, Lydia Montes, E. Martin, Aurore Perrot, Denis Caillot, Xavier Leleu, Karim Belhadj, Thierry Façon, Cyrille Hulin, Mohamad Mohty, Jean Fontan, Margaret Macro, Sabine Bréchignac, Arnaud Jaccard, Anne‐Marie Stoppa, Frédérique Orsini‐Piocelle, Didier Adiko, Laurent Voillat, Faiza Keddar, Marly Barry, Hélène Demarquette, Marie-Noëlle Certain, Isabelle Plantier, Murielle Roussel, Benjamin Hébraud, Thomas Filleron, Michel Attal, Hervé Avet‐Loiseau,
Tópico(s)PI3K/AKT/mTOR signaling in cancer
Referência(s)